Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 19.701% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cc1ccc(N(C(C)C(=O)Nc2c(C)n(C)n(-c3ccccc3)c2=O)S(C)(=O)=O)cc1C
(b) Cc1cc(C)n(-c2ccc(C(=O)NCCCN3CCOCC3)cc2)n1
Answer: b. Cc1cc(C)n(-c2ccc(C(=O)NCCCN3CCOCC3)cc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)n(-c2ccc(C(=O)NCCCN3CCOCC3)cc2)n1
Cc1cc(C)n(-c2ccc(C(=O)NCCCN3CCOCC3)cc2)n1
4-(3,5-dimethylpyrazol-1-yl)-N-(3-morpholin-4-ylpropyl)benzamide